Top Clinical Trials companies in Spain by Net Cash Used For Investing Activities
Spain
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD -1.74 M
|
Dec. 31, 2023 | USD 1.81 | -0.12% |
|
Spain |
|
| 2 |
USD -16.01 M
|
Dec. 31, 2023 | USD 1.52 | 0.94% |
|
Spain |
|
| 3 |
USD -57.43 M
|
Dec. 31, 2023 | USD 68.35 | 0.94% |
|
Spain |
|
| 4 |
USD -135.27 M
|
Dec. 31, 2023 | USD 9.63 | -2.28% |
|
Spain |
Frequently Asked Questions
-
Which Clinical Trials company in Spain has the highest Net Cash Used For Investing Activities ?
The Clinical Trials company in Spain with the highest Net Cash Used For Investing Activities is Pangaea Oncology, S.A. (MCE: PANG.MC) at USD -1.74 M.
-
Which Clinical Trials company in Spain has the lowest Net Cash Used For Investing Activities ?
The Clinical Trials company in Spain with the lowest Net Cash Used For Investing Activities is Almirall, S.A. (MCE: ALM.MC) at USD -135.27 M.
-
What are the top 10 Clinical Trials companies in Spain by Net Cash Used For Investing Activities ?
The top 10 Clinical Trials companies in Spain by Net Cash Used For Investing Activities are Pangaea Oncology, S.A., Oryzon Genomics S.A., Laboratorios Farmaceuticos Rovi, S.A. and Almirall, S.A..
-
What are the bottom 10 Clinical Trials companies in Spain by Net Cash Used For Investing Activities ?
The bottom 10 Clinical Trials companies in Spain by Net Cash Used For Investing Activities are Almirall, S.A., Laboratorios Farmaceuticos Rovi, S.A., Oryzon Genomics S.A. and Pangaea Oncology, S.A..
